Search

The Africa Phage Forum will be hosting a webinar on this Wednesday, 15th March 2023 at 6:00 PM East Africa Time (EAT). The webinar, titled ‘Scientific Writing & Effective Grant Writing’, will be given by Dr. Tobi Nagel, the Founder and Pres

The Good Virus is a new book by Tom Ireland that tells the story of phage research, from its beginnings to the present day. Now available for preorder in the UK and the US!

From Phage Twitter, via @hayleyn0rdstr0m: Adaptive Phage Therapeutics laid off 30% of the company this morning, including me… So, looking for phage research jobs in the DC metro area again! Drop me a DM if you have leads or want to chat.

The documentary, Salt in My Soul, follows the life of Mallory Smith, who was diagnosed with cystic fibrosis at age 3, and a resistant infection at age 15. In her final days, her father attempted to arrange phage therapy for her, but it was

In this study, Benjamin A. Adler (University of California, Berkeley) and colleagues used a high-throughput genetic screen to uncover genome-wide host suppressors of diverse single-gene lysis proteins (Sgls). See also this interview with th

Screen Australia has announced $4.6 million in production funding for 21 documentaries, including A Forgotten Cure (working title), a 54-minute phage therapy documentary that follows teams of scientists in Melbourne and Sydney (part of Phag

A new paper in Nature Microbiology by Madison C. Williams (University of Washington) and colleagues entitled Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy reports that restriction

In a new preprint, Enea Maffei (University of Basel) and colleagues describe a new phage, Paride, which is able to kill dormant, antibiotic-tolerant bacteria. They suggest that this phage hijacks weak spots in the dormant physiology of anti

In this JAMA Medical News & Perspectives article, Eli Cahan discusses the resurgence of interest in phage therapy in the wake of the COVID-19 pandemic.

The Good Virus is a new book by Tom Ireland that tells the story of phage research, from its beginnings to the present day. Now available for preorder in the UK and the US!

Our @PhageFiles podcast is finally here! Tune in on Spotify, Google Podcasts, Deezer and Amazon Music to listen to our first episodes. In our podcast we will discuss all things phage. You will hear from researchers and entrepreneurs interes

ESCMID (European Society of Clinical Microbiology and Infectious Diseases) is hosting a hands-on course on phage therapy 25 - 27 July 2023, Brussels, Belgium) -- register by 06 June 2023 (25 spaces only!).

BiomX Inc. announced positive results from Part 1 of the Phase 1b/2a trial evaluating their novel phage cocktail, BX004, for the treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

In a new paper in Viruses, Sandrine Le Guellec and colleagues describe a preclinical study involving macaques to predict the efficacy of delivery of nebulizer-administered Pseudomonas aeruginosa phages during mechanical ventilation. They fo

In a new paper in Food Microbiology, Marta Volpi and colleagues report on a full-scale industrial trial to evaluate the efficacy of a commercial phage product to reduce the prevalence of naturally occurring Salmonella on pork carcasses. The

In a new paper in Nature Microbiology, Charles Dulberger and colleagues show that the mycobacterial nucleoid-associated protein Lsr2 is required for productive mycobacteriophage infection.

A new paper in PNAS by Bin Li and colleagues discusses how viruses require the small polyamine spermidine to replicate normally, in part due to its important role in ribosomal translation. They found genes in many phages and eukaryotic viru

From the Phagebiotics Research Foundation: Greetings Phage friends! The 25th biennial International Evergreen Phage Meeting is set to kick off in person, in full Evergreen fashion, with Dr. Betty Kutter at the Evergreen State College. Mar

In a talk entitled “Bacteriophage Therapy: From Soviet Clinical Experience to Current Activities at the Eliava Institute”, Dr. Mzia Kutateladze (Eliava Institute of Bacteriophage, Georgia) will present her latest research at the Targeting P

Erytech (a red blood cell-based therapeutics company) and Pherecydes (a phage therapy company) will merge to form a new company, whose name is yet to be disclosed, and redirect Erytech's financial resources, people and network toward Pherec